基因敲除
胶质瘤
脱甲基酶
癌症研究
表皮生长因子受体
细胞生长
生物
细胞周期
细胞
细胞培养
组蛋白
受体
基因
生物化学
遗传学
作者
Qing Wang,Pei Y. Liu,Tao Liu,Qing Lan
出处
期刊:Anticancer Research
[Anticancer Research USA Inc.]
日期:2019-11-01
卷期号:39 (11): 6007-6014
被引量:7
标识
DOI:10.21873/anticanres.13806
摘要
The histone demethylase NO66 regulates gene and protein expression. Epidermal growth factor receptor (EGFR) is a key oncogenic factor for glioblastoma. This study aimed to examine the role of NO66 in glioblastoma.The prognostic value of NO66 expression in 263 human glioma tissues and 510 glioblastoma tissues was examined by Kaplan and Meier survival analysis. Immunoblot analysis of EGFR expression, cell proliferation assays and cell cycle analysis were performed in glioblastoma cells after NO66 knockdown.In 263 human glioma tissues, high levels of NO66 expression correlated with advanced disease stage and poor patient prognosis. In 510 glioblastoma tissues, high levels of NO66 expression also predicted poor patient prognosis. NO66 knockdown reduced EGFR expression and cell proliferation in glioblastoma cells.High levels of NO66 in glioma and glioblastoma tissues predict poor patient prognosis, and NO66 is required for EGFR expression and glioblastoma cell proliferation.
科研通智能强力驱动
Strongly Powered by AbleSci AI